Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-251.42%Earnings Yield
VS
Market
Sector
Industry
History
$ 1.73Close
$ 1.7 - $ 5.85 52-Week Range
Ticker Information
Ticker
PPCBCompany Name
PROPANC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPROPANC BIOPHARMA INC - Earnings Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PPCB - Earnings Yield Historical data
| Date | Earnings Yield | Market Capitalization | Net Income Common Stock |
|---|---|---|---|
| 6/30/2025 | -251.42% | $ 23.44M | $ -58.92M |
| 3/31/2025 | 0% | $ 0 | $ -55.21M |
| 12/31/2024 | 0% | $ 0 | $ -1.69M |
| 9/30/2024 | 0% | $ 0 | $ -1.87M |
| 6/30/2024 | 0% | $ 0 | $ -2.01M |
| 3/31/2024 | 0% | $ 0 | $ -2.46M |
| 12/31/2023 | 0% | $ 0 | $ -2.73M |
| 9/30/2023 | 0% | $ 0 | $ -2.61M |
| 6/30/2023 | 0% | $ 0 | $ -3.13M |
| 6/30/2022 | 0% | $ 0 | $ -3.36M |
Key Performance Insights, Last 5 Years
- PROPANC BIOPHARMA INC's latest trailing twelve months (TTM) Earnings Yield stands at 0%.
- Over the past 5 years, PROPANC BIOPHARMA INC's average Earnings Yield has been -251.42%.
- The median Earnings Yield for PROPANC BIOPHARMA INC during this period was -251.42%
- PROPANC BIOPHARMA INC reached its highest Earnings Yield over the past 5 years at -251.42%.
- The lowest Earnings Yield recorded by PROPANC BIOPHARMA INC in the same timeframe -251.42%
Similar metrics to Net Inc. Cmn.:
- Price to Earnings - [Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Definition of Earnings Yield
[Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].Net Inc. Cmn. / Market Cap
(=) Earnings Yield Earnings Yield for PROPANC BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ -3.36M ] / Market Cap [ $ 0 ]
(=) Earnings Yield [ 0% ] PPCB - Earnings Yield, Last 5 years
-251.42%
Minimum
Jun 30, 2025
-251.42%
Maximum
Jun 30, 2025
-251.42%
Average
-251.42%
Median
Earnings Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Earnings Yield for companies in the Total Stock Market. The average Earnings Yield of the companies is 0.34% with a standard deviation of 9.81%.
The following table provides additional summary stats:
Earnings Yield in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | -31.68% |
| max | 32.87% |
| average | 0.34% |
| median | 2.78% |
| std | 9.81% |